The consolidated case is titled In Re National Prescription Opioid Litigation, 17-MD-2804, U.S. District Court, Northern District of Ohio (Cleveland).
Teva and Allergan have reportedly been in mediation for more than a year.
In 2016, Teva completed a $40.5 billion acquisition of Allergan’s generic business, including generic opioids.
In 2020, AbbVie acquired Allergan.
Earlier this year, Teva Pharmaceuticals and AbbVie reached a deal with Rhode Island for a total of $28.5 million to settle opioid-related claims.